There have been significant efforts by the public and private sector to further secure our nation's drug supply from counterfeit drugs. In 2004, FDA released a framework as guidance for these efforts and has been facilitating the implementation of this framework. Technology-based solutions, such as using radio-frequency identification (RFID) as a means to create an electronic pedigree that documents the movement of a drug product through the drug supply chain, is an important element of the framework. In 2005, two years after the release of the framework, FDA issued an update reporting the progress on reaching the goals of the framework, including RFID implementation, use of electronic pedigree, the pedigree requirements under the Prescription Drug Marketing Act. This article summarizes the findings of FDA's Counterfeit Drug Task Force 2006 Update. A full copy of the report can be accessed at http://www.fda.gov/oc/initiatives/counterfeit/report6_06. pdf.1
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.